Ohwada Akihiko, Sato Katsuhiko
Ohwada Clinic, Chiba-ken, Japan.
Division of Respiratory Medicine, Juntendo University Faculty of Medicine and Graduate School of Medicine, Tokyo, Japan.
J Thorac Dis. 2019 Dec;11(12):5218-5227. doi: 10.21037/jtd.2019.11.72.
Cough-dominant or cough-variant asthma is common in Japan. However, it is unclear whether cough and dyspnea, the cardinal symptoms of bronchial asthma, are similarly perceived, and whether these symptoms are linked to pulmonary function tests.
The subjects were 548 physician-diagnosed naive patients with asthma. Visual analogue scale (VAS) scores were determined and spirometry was performed before and after 1-month inhaled corticosteroid/long-acting beta2 agonist therapy.
The patients were divided into those with a significant bronchodilating response and an increase in FEV (>12% and >200 mL) after treatment (n=146); and nonresponders without this response (n=402). Cough was more dominant than dyspnea in both groups at the initial evaluation. Both symptoms were diminished after treatment, but scores for cough remained significantly higher than those for dyspnea in nonresponders. VAS scores for dyspnea at both time points differed in responders and nonresponders, and changes of cough and dyspnea scores were larger in responders. In responders, peak expiratory flow (PEF) (absolute, %predicted) for cough and FEV (%predicted), VC (%predicted) and PEF (absolute) for dyspnea were correlated at both time points, but in nonresponders, neither cough nor dyspnea was related to a common spirometric parameter at both time points. Changes in cough and dyspnea scores were correlated with changes of FEV (absolute, %predicted) and FEF (absolute) for responders, while only PEF (%predicted) was correlated with these changes in nonresponders. Calculated slopes (ΔVAS score/ΔFEV) suggested that responders were more sensitive to dyspnea than nonresponders.
Perception of cough and dyspnea were similar, but not identical, for bronchodilating responders and nonresponders among patients with bronchial asthma. Linkage of pulmonary function parameters with perceptions of cough and dyspnea also differed between the responders and nonresponders.
在日本,以咳嗽为主型或咳嗽变异性哮喘很常见。然而,尚不清楚支气管哮喘的主要症状咳嗽和呼吸困难是否被同样感知,以及这些症状是否与肺功能测试相关。
研究对象为548例经医生诊断的初诊哮喘患者。在吸入糖皮质激素/长效β2受体激动剂治疗1个月前后,测定视觉模拟量表(VAS)评分并进行肺功能测定。
患者被分为治疗后有显著支气管舒张反应且FEV增加(>12%且>200 mL)的患者(n = 146);以及无此反应的无反应者(n = 402)。在初始评估时,两组中咳嗽均比呼吸困难更为突出。治疗后两种症状均减轻,但在无反应者中,咳嗽评分仍显著高于呼吸困难评分。有反应者和无反应者在两个时间点的呼吸困难VAS评分不同,且有反应者咳嗽和呼吸困难评分的变化更大。在有反应者中,咳嗽的呼气峰值流速(PEF)(绝对值、预测值%)以及呼吸困难的FEV(预测值%)、VC(预测值%)和PEF(绝对值)在两个时间点均相关,但在无反应者中,咳嗽和呼吸困难在两个时间点均与常见的肺功能参数无关。有反应者咳嗽和呼吸困难评分的变化与FEV(绝对值、预测值%)和FEF(绝对值)的变化相关,而在无反应者中只有PEF(预测值%)与这些变化相关。计算的斜率(ΔVAS评分/ΔFEV)表明,有反应者对呼吸困难比无反应者更敏感。
支气管哮喘患者中,支气管舒张反应者和无反应者对咳嗽和呼吸困难的感知相似但不完全相同。有反应者和无反应者之间肺功能参数与咳嗽和呼吸困难感知的关联也有所不同。